7 employees
MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.
2009
$50M
from 4 investors over 4 rounds
MitrAssist raised $50M on December 3, 2020
Investors: 6 Dimensions Capital, CITIC Capital, Fosun Pharma and Centurium Capital